BioCentury
ARTICLE | Financial News

Aveo raises $53 million

May 4, 2007 1:24 AM UTC

Aveo ( Cambridge, Mass.) raised $53 million in a series D round. New investors Biogen Idec (BIIB); Bessemer Venture Partners; Merlin BioMed Group; Mitsubishi UFJ; and Vatera Holdings joined existing investors Highland Capital; Venrock Associates; MPM Capital; Prospect Ventures; Flagship Ventures; Oxford Bioscience Partners; Greylock Partners; Lotus BioSciences; and GE Capital in the round. The financing includes a $10 million equity investment from Schering-Plough (SGP) as part of a deal in which Aveo granted SGP an exclusive worldwide license to develop and commercialize AV-299, a preclinical MAb for cancer (See BioCentury Extra, Wednesday, April 04, 2007). ...